Peter Hirth is Director of Vaxcyte, Inc.. Currently has a direct ownership of 7,175 shares of PCVX, which is worth approximately $624,799. The most recent transaction as insider was on Jun 06, 2024, when has been sold 1,550 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.18K
0% 3M change
27.56% 12M change
Total Value Held $624,799

Peter Hirth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
1,550 Added 17.77%
7,175 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
2,500 Added 30.77%
5,625 Common Stock
Jun 01 2022
BUY
Grant, award, or other acquisition
-
3,125 Added 50.0%
3,125 Common Stock

Also insider at

ALGS
Aligos Therapeutics, Inc. Healthcare
IOBT
IO Biotech, Inc. Healthcare
PH

Peter Hirth

Director
San Carlos, CA

Track Institutional and Insider Activities on PCVX

Follow Vaxcyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX